{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:48:49Z","timestamp":1791938929135,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare serial prenatal MRI findings in valacyclovir-treated vs untreated fetuses with confirmed congenital cytomegalovirus (cCMV) infection, focusing on the occurrence and timing of minor brain lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>In this retrospective single-center cohort study, fetuses with confirmed cCMV infection and at least two prenatal brain MRI examinations were included. Fetuses with major brain malformations at baseline were excluded. Treated fetuses received oral valacyclovir (8\u2009g\/day) from diagnosis to delivery. Two senior neuroradiologists assessed MRI examinations in consensus, focusing on minor lesions (temporal pole T2 hyperintensity, focal temporal horn dilation, small cysts). Lesion timing was categorized as absent, late-onset, or early-onset. Statistical analyses included Fisher\u2019s exact test, \u03c7\u00b2-test, and odds ratios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy-seven fetuses were included (62 untreated, 15 treated). Persistently negative MRI findings were observed in 73.3% of treated fetuses vs 37.1% of untreated fetuses (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018; OR 4.67, 95% CI: 1.29\u201316.9). Early-onset minor lesions were observed only in untreated fetuses (11.3%). A significant difference between groups was confirmed when analysis was restricted to temporal pole lesions (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Maternal valacyclovir therapy was associated with a significantly higher likelihood of persistently normal prenatal MRI findings and absence of early minor brain lesions, suggesting a protective effect on fetal brain involvement in cCMV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Minor temporal pole lesions are common early MRI findings in cCMV<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Valacyclovir-treated fetuses showed fewer and later-onset minor lesions<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Serial fetal MRI may serve as an imaging surrogate marker of treatment response<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-026-12698-y","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:39:39Z","timestamp":1781951979000},"page":"8140-8148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serial prenatal MRI evaluation of valacyclovir-treated vs untreated fetuses with congenital cytomegalovirus (cCMV) infection"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-3061","authenticated-orcid":false,"given":"Mario","family":"Tortora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Arossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Furione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Chiapparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giana","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Parazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Arrigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Criscuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Lanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Righini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Doneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"12698_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1276912","volume":"11","author":"S Salom\u00e8","year":"2023","unstructured":"Salom\u00e8 S, Corrado FR, Mazzarelli LL et al (2023) Congenital cytomegalovirus infection: the state of the art and future perspectives. Front Pediatr 11:1276912. https:\/\/doi.org\/10.3389\/fped.2023.1276912","journal-title":"Front Pediatr"},{"key":"12698_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2024.100257","volume":"7","author":"SM Lawrence","year":"2024","unstructured":"Lawrence SM (2024) Human cytomegalovirus and neonatal infection. Curr Res Microb Sci 7:100257. https:\/\/doi.org\/10.1016\/j.crmicr.2024.100257","journal-title":"Curr Res Microb Sci"},{"key":"12698_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/pd.5180","volume":"37","author":"R Birnbaum","year":"2017","unstructured":"Birnbaum R, Ben-Sira L, Lerman-Sagie T, Malinger G (2017) The use of fetal neurosonography and brain MRI in cases of cytomegalovirus infection during pregnancy: a retrospective analysis with outcome correlation. Prenat Diagn 37:1335\u20131342. https:\/\/doi.org\/10.1002\/pd.5180","journal-title":"Prenat Diagn"},{"key":"12698_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pediatrneurol.2024.03.001","volume":"155","author":"C Doneda","year":"2024","unstructured":"Doneda C, Scelsa B, Introvini P et al (2024) Congenital cytomegalovirus infection with isolated minor lesions at fetal magnetic resonance imaging: long-term neurological outcome. Pediatr Neurol 155:104\u2013113. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2024.03.001","journal-title":"Pediatr Neurol"},{"key":"12698_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1471-0528.2007.01308.x","volume":"114","author":"F Jacquemard","year":"2007","unstructured":"Jacquemard F, Yamamoto M, Costa JM et al (2007) Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 114:1113\u20131121. https:\/\/doi.org\/10.1111\/j.1471-0528.2007.01308.x","journal-title":"BJOG"},{"key":"12698_CR6","doi-asserted-by":"publisher","first-page":"462.e1","DOI":"10.1016\/j.ajog.2016.04.003","volume":"215","author":"M Leruez-Ville","year":"2016","unstructured":"Leruez-Ville M, Ghout I, Bussi\u00e8res L et al (2016) In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol. 215:462.e1\u2013462.e10. https:\/\/doi.org\/10.1016\/j.ajog.2016.04.003","journal-title":"Am J Obstet Gynecol."},{"key":"12698_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00006254-200204000-00024","volume":"57","author":"MA Gaytant","year":"2002","unstructured":"Gaytant MA, Steegers EAP, Semmekrot BA, Merkus HMMW, Galama JMD (2002) Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 57:245\u2013256","journal-title":"Obstet Gynecol Surv"},{"key":"12698_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/uog.23685","volume":"58","author":"V Faure-Bardon","year":"2021","unstructured":"Faure-Bardon V, Fourgeaud J, Stirnemann J, Leruez-Ville M, Ville Y (2021) Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy. Ultrasound Obstet Gynecol 58:576\u2013581. https:\/\/doi.org\/10.1002\/uog.23685","journal-title":"Ultrasound Obstet Gynecol"},{"key":"12698_CR9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/jac\/dkae470","volume":"80","author":"V Faure-Bardon","year":"2025","unstructured":"Faure-Bardon V, Bouazza N, Benaboud S et al (2025) Quantification of maternal and fetal valaciclovir exposure in a pharmacokinetic study of cytomegalovirus-infected pregnant women treated to prevent vertical transmission. J Antimicrob Chemother 80:760\u2013766. https:\/\/doi.org\/10.1093\/jac\/dkae470","journal-title":"J Antimicrob Chemother"},{"key":"12698_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ajog.2023.07.022","volume":"230","author":"C Chatzakis","year":"2024","unstructured":"Chatzakis C, Shahar-Nissan K, Faure-Bardon V et al (2024) The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy: an individual patient data meta-analysis. Am J Obstet Gynecol 230:109\u2013117.e2. https:\/\/doi.org\/10.1016\/j.ajog.2023.07.022","journal-title":"Am J Obstet Gynecol"},{"key":"12698_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/uog.26136","volume":"61","author":"F D\u2019Antonio","year":"2023","unstructured":"D\u2019Antonio F, Marinceu D, Prasad S, Khalil A (2023) Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis. Ultrasound Obstet Gynecol 61:436\u2013444. https:\/\/doi.org\/10.1002\/uog.26136","journal-title":"Ultrasound Obstet Gynecol"},{"key":"12698_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1515\/jpm-2023-0535","volume":"52","author":"M Vicente","year":"2024","unstructured":"Vicente M, Carocha AI, Rijo C, Cohen \u00c1, Martins ML (2024) Cytomegalovirus congenital infection: long-term outcomes in a valaciclovir-treated population. J Perinat Med 52:778\u2013782. https:\/\/doi.org\/10.1515\/jpm-2023-0535","journal-title":"J Perinat Med"},{"key":"12698_CR13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00330-011-2340-y","volume":"22","author":"DO Cosgrove","year":"2012","unstructured":"Cosgrove DO, Berg WA, Dor\u00e9 CJ et al (2012) Neuroimaging in congenital cytomegalovirus infection. Eur Radiol 22:1023\u20131030","journal-title":"Eur Radiol"},{"key":"12698_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.humimm.2004.02.009","volume":"65","author":"G Gerna","year":"2004","unstructured":"Gerna G, Baldanti F, Revello MG (2004) Pathogenesis of human cytomegalovirus infection and cellular targets. Hum Immunol 65:381\u2013386. https:\/\/doi.org\/10.1016\/j.humimm.2004.02.009","journal-title":"Hum Immunol"},{"key":"12698_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.4437","volume":"235","author":"P Griffiths","year":"2015","unstructured":"Griffiths P, Baraniak I, Reeves M (2015) The pathogenesis of human cytomegalovirus. J Pathol 235:288\u2013297. https:\/\/doi.org\/10.1002\/path.4437","journal-title":"J Pathol"},{"key":"12698_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00401-011-0895-y","volume":"122","author":"N Teissier","year":"2011","unstructured":"Teissier N, Delezoide AL, Mas AE et al (2011) Inner ear lesions in congenital cytomegalovirus infection of human fetuses. Acta Neuropathol 122:763\u2013774. https:\/\/doi.org\/10.1007\/s00401-011-0895-y","journal-title":"Acta Neuropathol"},{"key":"12698_CR17","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jama.289.8.1008","volume":"289","author":"KB Fowler","year":"2003","unstructured":"Fowler KB, Stagno S, Pass RF (2003) Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 289:1008\u20131011. https:\/\/doi.org\/10.1001\/jama.289.8.1008","journal-title":"JAMA"},{"key":"12698_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2174\/187152611797636721","volume":"11","author":"MR Schleiss","year":"2011","unstructured":"Schleiss MR (2011) Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infect Disord Drug Targets 11:449\u2013465. https:\/\/doi.org\/10.2174\/187152611797636721","journal-title":"Infect Disord Drug Targets"},{"key":"12698_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.101101","volume":"5","author":"L Zammarchi","year":"2023","unstructured":"Zammarchi L, Tomasoni LR, Liuzzi G et al (2023) Treatment with valacyclovir during pregnancy for prevention of congenital cytomegalovirus infection: a real-life multicenter Italian observational study. Am J Obstet Gynecol MFM 5:101101. https:\/\/doi.org\/10.1016\/j.ajogmf.2023.101101","journal-title":"Am J Obstet Gynecol MFM"},{"key":"12698_CR20","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1080\/14767058.2020.1815188","volume":"35","author":"M De la Calle","year":"2022","unstructured":"De la Calle M, Baquero-Artigao F, Rodr\u00edguez-Molino P et al (2022) Combined treatment with immunoglobulin and valaciclovir in pregnant women with cytomegalovirus infection and high risk of symptomatic fetal disease. J Matern Fetal Neonatal Med 35:3196\u20133200. https:\/\/doi.org\/10.1080\/14767058.2020.1815188","journal-title":"J Matern Fetal Neonatal Med"},{"key":"12698_CR21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2610","volume":"139","author":"TM Lanzieri","year":"2017","unstructured":"Lanzieri TM, Chung W, Flores M et al (2017) Hearing loss in children with asymptomatic congenital cytomegalovirus infection. Pediatrics 139:e20162610. https:\/\/doi.org\/10.1542\/peds.2016-2610","journal-title":"Pediatrics"},{"key":"12698_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/uog.23143","volume":"57","author":"D Buca","year":"2021","unstructured":"Buca D, Di Mascio D, Rizzo G et al (2021) Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol 57:551\u2013559. https:\/\/doi.org\/10.1002\/uog.23143","journal-title":"Ultrasound Obstet Gynecol"},{"key":"12698_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/INF.0000000000004583","volume":"44","author":"S Villaverde","year":"2025","unstructured":"Villaverde S, Pedrero-Tom\u00e9 R, Papaevangelou V et al (2025) Antiviral treatment and risk of hearing loss in asymptomatic and mild symptomatic infants with congenital cytomegalovirus. Pediatr Infect Dis J 44:239\u2013245. https:\/\/doi.org\/10.1097\/INF.0000000000004583","journal-title":"Pediatr Infect Dis J"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12698-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-026-12698-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12698-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:02:47Z","timestamp":1791936167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-026-12698-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["12698"],"URL":"https:\/\/doi.org\/10.1007\/s00330-026-12698-y","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The scientific guarantor of this publication is Mario Tortora.","order":1,"name":"Ethics","label":"Guarantor","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No complex statistical methods were necessary for this paper.","order":3,"name":"Ethics","label":"Statistics and biometry","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Institutional Review Board approval was obtained.","order":5,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No study subjects or cohorts have been previously reported.","order":6,"name":"Ethics","label":"Study subjects or cohorts overlap","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"order":7,"name":"Ethics","label":"Methodology","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}